Adverse reactions to drug withdrawal

Adverse Drug Reaction Bulletin

Volumn , Issue 187, 1997, Pages 711-714

  Routledge, P A ^a,b   Bialas, M C ^b  

^a Department of Clinical Pharmacology ^*

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OPIATE; TRANQUILIZER;

HUMAN; PRENATAL EXPOSURE; RISK BENEFIT ANALYSIS; SHORT SURVEY; WITHDRAWAL SYNDROME;

EID: 0031468708     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-199712000-00001     Document Type: Short Survey

References (70)

1. Routledge PA. Adverse reactions to drug withdrawal. Adverse Drug Reaction Bulletin. 1977; 67: 236-9.
2. Guthrie SK. The treatment of alcohol withdrawal. Pharmacotherapy 1989; 9: 131-43.
3. Farrell M. Opiate withdrawal. Addiction 1994; 89: 1471-5.
4. West R, Gossop M. Overview; a comparison of withdrawal symptoms from different drug classes. Addiction 1994; 89: 1483-9.
5. Petursson H. The benzodiazepine withdrawal syndrome. Addiction 1994; 89: 1455-9.
6. Dorian P, Sellers EM, Kaplan H, Hamilton C. Evaluation of zopiclone physical dependence liability in normal volunteers. Pharmacology 1983; 27 (Suppl 2): 228-34.
7. Kane FJ. Significance of seizures in patients receiving psychotropic drugs. Journal of the American Medical Association 1965; 194: 296.
8. Reilly TM. Physiological dependence on, and symptoms of withdrawal from, chlormethiazole. British Journal of Psychiatry 1976; 128: 375-8.
9. Hobbs WR, Rall TW, Verdoom TA. Hypnotics and sedatives; ethanol. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 361-98.
10. Klein DF, Davis JM. Diagnosis and treatment of psychiatric disorders. Baltimore: Williams and Wilkins, 1969.
11. Pary RJ, Klontz W, Foxworth JM. Cholinergic rebounds and withdrawal syndromes. American Journal of Psychiatry 1980; 137: 261.
12. Brooks GW. Withdrawal from neuroleptic drugs. American Journal of Psychiatry 1959; 115: 932.
13. Hodding GC, Jann M, Ackerman IP. Drug withdrawal syndromes - a literature review. Western Journal of Medicine 1980; 133: 383-91.
14. Burkitt EA, Faulkner M. Pimozide. British Medical Journal 1972; 3: 643.
15. Cape G. Neuroleptic malignant syndrome - a cautionary tale and a surprising outcome. British Journal of Psychiatry 1994; 164: 120-2.
16. Sathananthan GL, Gershon S. Imipramine withdrawal: an akathisia-like syndrome. American Journal of Psychiatry 1973; 130: 1286-7.
17. Dilsaver SC. Withdrawal phenomena associated with antidepressant and antipsychotic agents. Drug Safety 1994; 10: 103-14.
18. Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Annals of Pharmacotherapy 1995; 29: 1284-5.
19. Dominguez RA, Goodnick PJ. Adverse events after the abrupt discontinuation of paroxetine. Pharmacotherapy 1995; 15: 778-80.
20. Einbinder E. Fluoxetine withdrawal? American Journal of Psychiatry 1995; 152: 1235.
21. Bloch M, Stager SV, Braun AR, Rubinow DR. Severe psychiatric symptoms associated with paroxetine withdrawal. Lancet 1995; 346: 57.
22. Liskin B, Roose SP, Walsh BT, Jackson WK. Acute psychosis following phenelzine discontinuation. Journal of Clinical Psychopharmacology 1985; 5: 46-7.
23. Rothschild AJ. Mania after withdrawal of isocarboxazid. Jounal of Clinical Psychopharmacology 1985; 5: 340-2.
24. Absher JR, Black DW. Tranylcypromine withdrawal delirium. Journal of Clinical Psychopharmacology 1988; 8: 379-80.
25. Hughes RC, Polgar JG, Weightman D, Walton JN. Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs. British Medical Journal 1971; 2: 487-91.
26. McInnis M, Petursson H. Withdrawal of trihexyphenidyl. Acta Psychiatrica Scandinavica 1985; 71: 297-303.
27. Olivera AA, Evans M. Chronic anticholinergic administration: dependence withdrawal syndrome, and treatment. Current Therapeutic Research 1988; 44: 325-8.
28. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 199-248.
29. Schildkraut JJ, Watson R, Draskoczy PR. Amphetamine withdrawal: depression and MHPG excretion. Lancet 1971; 2: 485-6.
30. Oswald I, Lewis SA, Dunleavy DL, Brezinova V, Briggs M. Drugs of dependence though not of abuse: fenfluramine and imipramine. British Medical Journal 1971; 3: 70-3.
31. American Medical Association Department of Drugs. AMA Drug Evaluations, Phentermine, 5th ed. Chicago, IL: American Medical Association, 1983.
32. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993; 43: 483-8.
33. Roussounis SH. Benign intracranial hypertension after withdrawal of topical steroids in an infant. British Medical Journal 1976; 2: 564.
34. Liu GT, Kay MD, Bienfang DC, Schatz NK. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. American Journal of Ophthalmology 1994; 117: 352-7.
35. Hargreave FE, McCarthy DS, Pepys J. Steroid "pseudorheumatism" in asthma. British Medical Journal 1969; 1: 443-4.
36. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Safety 1994; 11: 163-78.
37. Browne SG. Nodular panniculitis and peripheral neuropathy following sudden withdrawal of corticosteroids. (Poststeroid nodular panniculitis). International Journal of Leprosy 1965; 33: 893-5.
38. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiotogical study of 104 cases. British Journal of Dermatology 1968; 80: 771-93.
39. Boxley JD, Dawber RP, Summerly R. Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment. British Medical Journal 1975; 2: 255-6.
40. Stegman SJ. Pustular dermatosis after withdrawal of topically applied steroids. Archives of Dermatology 1974; 109: 100.
41. Castellino RA, Glatstein E, Turbow MM, Rosenberg S, Kaplan HS. Latent radiation injury of lungs or heart activated by steroid withdrawal. Annals of Internal Medicine 1974; 80: 593-9.
42. Reid JL, Wing LM, Dargie HJ, Hamilton CA, Davies DS, Dollery CT. Clonidine withdrawal in hypertension, changes in blood pressure and plasma and urinary noradrenaline. Lancet 1977; 1: 1171-4.
43. Burden AC, Alexander CP. Rebound hypertension after acute methyldopa withdrawal. British Medical Journal 1976, 1: 1056-7
44. Alderman EL, Coltart DJ, Wettach GE, Harrison DC. Coronary artery syndromes after sudden propranolol withdrawal. Annals of Internal Medicine 1974; 81: 625-7.
45. Allen R, Genovese B. Propranotol withdrawal. Annals of Internal Medicine 1975; 82: 431.
46. Maling TJB. Beta blocker withdrawal: the role of the beta adrenoceptor. New Zealand Medical Journal 1984; 97: 76-7.
47. Ross PJ, Lewis MJ Sheridan DJ, Henderson AH. Adrenergic hypersensitivity after beta blocker withdrawal. British Heart Journal 1981; 45: 637-42.
48. 1) after long term treatment in patients with stable angina pectoris. European Heart Journal 1988; 9: 1339-47.
49. Ferratini M. Risk of rebound phenomenon during nitrate withdrawal. International Journal of Cardiolology 1994; 45: 89-96.
50. Michaels L, Beamish RE. Relapses of thromboembolic disease after discontinued anticoagulant therapy. A comparison of the incidence after abrupt and after gradual termination of treatment. American Journal of Cardiology 1967; 20: 670-3.
51. Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants - a prospective study. Thrombosis and Haemostasis 1994; 72: 222-6.
52. Smith AJ, Holt RE, Fitzpatrick JB, et al. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty. American Heart Journal 1996; 131: 434-9.
53. Granger CB, Miller JM, Bovill EG, et al. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995; 91: 1929-35.
54. Banos JE, Bosch F, Farre M. Drug-induced priapism. Its aetiology, incidence and treatment. Medical Toxicology and Adverse Drug Experience 1989; 4: 46-58.
55. MacGregor GA, Tasker PR, de . Wardener HE. Diuretic-induced oedema. Lancet 1975; 1: 489-92.
56. Lees AJ, Clarke CR, Harrison MJ. Hallucinations after withdrawal of baclofen. Lancet 1977; 1: 858.
57. Kirubakaran V, Mayfield D, Rengachary S. Dyskinesia and psychosis in a patient following baclofen withdrawal. American Journal of Psychiatry 1984; 141: 692-3.
58. Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesthesia and Analgesia 1995; 80: 1054-6.
59. Sardemann H, Madsen KS, Friis-Hansen B. Follow-up of children of drug-addicted mothers. Archives of Diseases in Childhood 1976; 51: 131-4.
60. Blinick G, Jerez E, Wallach RC. Methadone maintenance, pregnancy, and progeny. Journal of the American Medical Association 1973; 225: 477-9.
61. Olofsson M, Buckley W, Andersen GE, Friis-Hansen B. Investigation of 89 children born by drug-dependent mothers. Acta Paediatrica Scandinavica 1983; 72: 403-10.
62. Athinarayanan P, Pierog SH, Nigam SK, Glaso L. Chlordiazepoxide withdrawal in the neonate. American Journal of Obstetrics and Gynecology 1976; 124: 212-13.
63. Bleyer WA, Marshall RE. Barbiturate withdrawal syndrome in a passively addicted infant. Journal of the American Medical Association 1972; 221: 185-6.
64. Parkin DE. Probable Benadryl withdrawal manifestations in a newborn infant. Journal of Pediatrics 1974; 85: 580.
65. Prenner BM. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride. American Journal of Diseases of Children 1977; 131, 529-30.
66. Webster PA. Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet, 1973; 2: 318-9.
67. Eggermont E. Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet. 1973, 2, 680.
68. Ramer CM. The case history of an infant born to an amphetamine-addicted mother. Clinical Pediatrics 1975; 13: 596-7.
69. Billing L, Eriksson M, Larsson G, Zetterstroem R. Amphetamine addiction and pregnancy. Acta Paediatrica Scandinavica 1980; 69: 675-80.
70. Eriksson M, et al Amphetamine addiction and pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1981; 60: 253-9.